CAS 1189902-21-3

Carbamazepine-d2 (Major)

Controlled Product

CAS: 1189902-21-3

Applications Labelled Carbamazepine (C175840). Used in treatment of pain associated with trigeminal neuralgia. Anticonvulsant.
References Stenger, E.G., et al.: Med. Exp., 11, 191 (1964), Pynnonen, S., et al.: Ther. Drug Monit., 1, 409 (1979), Sidebottom, A., et al.: J. Clin. Pharm. Ther., 20, 31 (1995)

Formula: C₁₅H₁₀D₂N₂O

Color and Shape: Neat

Molecular weight: 238.28

Ref: TR-C175843

Carbamazepine-d2

Controlled Product

CAS: 1189902-21-3

Carbamazepine-d2 is an analog of carbamazepine, a medication used to treat epilepsy and bipolar disorder. It has been shown to have potential anticancer properties by inhibiting elastase activity and kinase signaling pathways in cancer cells. In Chinese hamster ovary cells, carbamazepine-d2 has been found to induce apoptosis and inhibit tumor growth. This compound can also be used as a protein kinase inhibitor in various research applications. Carbamazepine-d2 has been detected in human urine and may have potential as a biomarker for cancer diagnosis or treatment monitoring.

Formula: C₁₅H₁₂N₂O

Purity: Min. 95%

Molecular weight: 238.28 g/mol

Ref: 3D-PXB90221